ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Avantor completes VWR acquisition

by Marc S. Reisch
November 27, 2017 | APPEARED IN VOLUME 95, ISSUE 47

Avantor, a minnow in the laboratory supply business with about $700 million in annual sales, has completed its acquisition of VWR, a whale in the industry with $4.5 billion in sales. The combination, valued at $6.5 billion, will benefit from “deeper access to the high-growth biopharma, industrial, and applied research sectors,” says Avantor CEO Michael Stubblefield. The new firm will retain the Avantor name; the VWR name remains as a sales channel. Avantor was created in 2010 by the private equity firm New Mountain Capital through the acquisition of lab chemical maker Mallinckrodt Baker.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment